Table 1.
Characteristics | N = 130 |
---|---|
Age, mean (SD) | 5.3 (0.7%) |
Male | 80 (62%) |
Allergic diseases ever | |
Atopic eczema | 74 (57%) |
Symptoms within past 12 months | 50 (38%) |
Allergic rhinitis diagnosis | 91 (70%) |
Symptoms within past 12 months | 109 (84%) |
Adverse reaction to food | 48 (37%) |
Adverse reaction to bee or wasp | 20 (15%) |
Adverse reaction to latex | 1 (1%) |
Asthma severity | |
Intermittent | 32 (25%) |
Mild persistent | 77 (59%) |
Moderate persistent | 21 (16%) |
Severe persistent | 0 (0%) |
Asthma treatment during last 3 months | |
Inhaled corticosteroid | 108 (83%) |
Leukotriene receptor antagonist | 55 (42%) |
Long‐acting beta2‐agonist | 20 (51%) |
Status at study entry | |
Skin prick test positive for aeroallergens | 72 (55%) |
Peak expiratory flow | |
>80% | 101/121 (83%) |
60%‐80% | 16/121 (13%) |
<60% | 4/121 (3%) |
Parental smoking | 44 (34%) |
Parental allergic illnesses ever | |
Eczema | 47 (36%) |
Allergic rhinitis | 81 (62%) |
Asthma | 51 (39%) |
Adverse reaction to food | 34 (26%) |
Animal exposure on a weekly basis | |
Indoor pets | 54 (42%) |
Cat | 24/77 (31%) |
Dog | 30/76 (39%) |
Farm animal | 4/76 (5%) |
Other | 17/76 (22%) |
Breastfed | 110 (85%) |
Vitamin D supplementation | 45/119 (38%) |
In milk | 62/112 (55%) |
In cereal | 40/103 (39%) |
In yogurt | 48/112 (43%) |
Data are shown as number of patients (%) unless otherwise expressed.
See more patient characteristics in Table S1.